> A new study of the popular antibiotic Tequin shows it is linked to threatening changes in the level of blood glucose. Report
> The Department of Health and Human Services has ordered more than 14 million doses of antiviral drugs from Roche and GlaxoSmithKline in preparation for a potential bird flu pandemic. The Bush administration plans to treat about 25 percent of the population in the event of a pandemic, but there are no assurances that the drugs will work against a mutation in the virus that triggers human-to-human transmission. Report
> HHS Secretary Michael Leavitt says that bird flu may soon appear in domesticated and wild bird flocks in the U.S. Article
> The U.K.'s Alizyme has reported positive results from a Phase IIa trial of ATL-104 for mucositis. Release
> Rebel investors at SkyePharma renewed calls to install Bob Thian as the new chairman at the March 9 Extraordinary General Meeting. Report
> King Pharmaceuticals has acquired the exclusive rights to market and sell EpiPen in Canada from Allerex Laboratory. Release
> Novelos Therapeutics announced a $12.9 million private placement. Release
> BioScrip has acquired Intravenous Therapy Services for $13 million plus earn-out payments. Release
> And Finally… The New York Times examines the sudden popularity of Byetta, a new diabetes drug that has helped diabetics shed pounds and regain their health. Article